N-acetylcysteine in COPD may be beneficial, but for whom?

被引:16
作者
Cazzola, Mario [1 ]
Matera, Maria Gabriella
机构
[1] Univ Roma Tor Vergata, Dept Syst Med, Unit Resp Clin Pharmacol, I-00133 Rome, Italy
关键词
D O I
10.1016/S2213-2600(13)70294-7
中图分类号
R4 [临床医学];
学科分类号
100218 [急诊医学];
摘要
引用
收藏
页码:166 / 167
页数:2
相关论文
共 16 条
[1]
N-acetylcysteine - passe-partout or much ado about nothing? [J].
Aitio, ML .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (01) :5-15
[2]
Anderson David, 2009, Int J Chron Obstruct Pulmon Dis, V4, P321
[3]
[Anonymous], 2013, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease, Updated
[4]
[Anonymous], HIGH DOSE N ACETYLCY
[5]
[Anonymous], LANCET RESP MED
[6]
[Anonymous], CLIN THER
[7]
EFFECT OF N-ACETYLCYSTEINE ON PLASMA CYSTEIN AND GLUTATHIONE FOLLOWING PARACETAMOL ADMINISTRATION [J].
BURGUNDER, JM ;
VARRIALE, A ;
LAUTERBURG, BH .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 36 (02) :127-131
[8]
Effect of high-dose N-acetylcysteine on airway geometry, inflammation, and oxidative stress in COPD patients [J].
De Backer, Jan ;
Vos, Wim ;
Van Holsbeke, Cedric ;
Vinchurkar, Samir ;
Claes, Rita ;
Parizel, Paul M. ;
De Backer, Wilfried .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2013, 8 :569-579
[9]
Long-term oral n-acetylcysteine reduces exhaled hydrogen peroxide in stable COPD [J].
De Benedetto, F ;
Aceto, A ;
Dragani, B ;
Spacone, A ;
Formisano, S ;
Pela, R ;
Donner, CF ;
Sanguinetti, CM .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2005, 18 (01) :41-47
[10]
Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS):: a randomised placebo-controlled trial [J].
Decramer, M ;
Rutten-van Mölken, M ;
Dekhuijzen, PNR ;
Troosters, T ;
van Herwaarden, C ;
Pellegrino, R ;
van Schayck, CPO ;
Olivieri, D ;
Del Donno, M ;
De Backer, W ;
Lankhorst, I ;
Ardia, A .
LANCET, 2005, 365 (9470) :1552-1560